Heligenics Overview

  • Founded
  • 2015

  • Status
  • Private

  • Employees
  • 11

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.18M

  • Investors
  • 2

Heligenics General Information


Developer of a medicinal drug intended to prevent disease and heal patients afflicted with illness through genomics. The company's platform revolutionizes genetic testing and drug discovery by determining the function of genetic variation can comprehensively measure the functional significance of naturally occurring mutations in the human genome, enhancing the accuracy of genetic testing whether for rare diseases or cancer, enabling the medical industry to get an enhanced genetic test interpretation and the pharmaceutical companies to empower conversion of generic drugs into targeted precision medicines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Primary Office
  • 833 Las Vegas Boulevard North
  • Suite B
  • Las Vegas, NV 89101
  • United States
+1 (415) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Heligenics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 15-Dec-2020 $1.18M 00.000 00.000 Completed Generating Revenue
1. Grant 01-Jan-2015 00.00 Completed Generating Revenue
To view Heligenics’s complete valuation and funding history, request access »

Heligenics Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00.0 00.0 00.0 00 00.0 00.000
To view Heligenics’s complete cap table history, request access »

Heligenics Executive Team (2)

Name Title Board Seat Contact Info
Martin Schiller Ph.D Founder, Chief Executive Officer & Chairman
You’re viewing 1 of 2 executive team members. Get the full list »

Heligenics Board Members (5)

Name Representing Role Since
Asa Lanum Self Chairman of Advisory Board 000 0000
Martin Schiller Ph.D Heligenics Founder, Chief Executive Officer & Chairman 000 0000
Scott Hallman Heligenics Board Member 000 0000
Stan Schiller Self Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Heligenics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Heligenics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Battle Born Growth Venture Capital Minority 000 0000 000000 0
Nevada Governor's Office of Economic Development Government 000 0000 000000 0
To view Heligenics’s complete investors history, request access »